C10orf90 and glioblastoma: The results, as illustrated in Figure 7A, demonstrate a notable disparity in the expression levels of C10orf90 across various immune subtypes of multiple cancers, including BRCA, GBM, HNSC, LUSC, SARC, THCA, and UVM.